Protein Engineered By Researchers Has Potential For New Anti-Inflamatory Treatment

Main Category: Arthritis / Rheumatology
Also Included In: Crohn’s / IBD
Article Date: 11 Mar 2011 – 3:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:not yet rated

Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.

NextGen Healthcare Client, Grace Community Health Center, Receives Medicaid EHR Incentives With Support Of Kentucky REC

Main Category: IT / Internet / E-mail
Also Included In: Medicare / Medicaid / SCHIP
Article Date: 11 Mar 2011 – 1:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced that Gray, Ky.-based Grace Community Health Center, has secured in excess of $150,000 in state Medicaid incentives by demonstrating its recent selection of the company’s certified electronic health records (EHR) solution.

Budget Solution? Modernizing Medicaid Pharmacy Could Save Florida $473 Million

Main Category: Medicare / Medicaid / SCHIP
Also Included In: Pharmacy / Pharmacist
Article Date: 11 Mar 2011 – 4:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:3 stars

3 (1 votes)

As Florida legislators seek ways to reduce Medicaid spending, they should start by transitioning the entire pharmacy benefits program from the archaic fee-for-service model to the more efficient model used in some parts of the state.

Key To Cancer, Arthritis And Cardiac Treatments Could Be The ADAM-12 Gene

Main Category: Genetics
Also Included In: Cancer / Oncology;  Arthritis / Rheumatology;  Cardiovascular / Cardiology
Article Date: 10 Mar 2011 – 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

ADAM-12 is not only the name of a 1970’s television police drama – it’s also the gene that University of Missouri researchers believe could be an important element in the fight against cancer, arthritis, and cardiac hypertrophy, or thickening of the heart’s walls.

Aetna Launches Program To Improve Asthma Outcomes Of African American And Hispanic Medicaid Members In Delaware

Main Category: Medicare / Medicaid / SCHIP
Also Included In: Respiratory / Asthma
Article Date: 09 Mar 2011 – 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

Aetna (NYSE: AET) announced a pilot program for its Medicaid members in Delaware. This program aims to improve health outcomes of Hispanic and African American patients who struggle with asthma. The pilot is a year-long initiative that adds new health care interventions to better control asthma and help reduce the need for emergency room visits.

NYSNA Launches Ad Campaign Promoting “Go Slower” Approach For Medicaid Reform

Main Category: Medicare / Medicaid / SCHIP
Article Date: 09 Mar 2011 – 2:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

The New York State Nurses Association (NYSNA) has launched a multi-media advertising campaign to draw attention to the flaws in existing plans for $2.3 billion in reductions proposed for the Medicaid program. The ad campaign advocates for a “go slower” approach on Medicaid reform to allow time for a carefully considered Medicaid redesign process. Medicaid serves 4.7 million of New York’s most vulnerable residents and is a linchpin for the state’s healthcare safety net.

First-Of-Its-Kind Pilot Study Using Image-Guided Neurothermal Ablation For Premature Ejaculation

Main Category: Erectile Dysfunction / Premature Ejaculation
Also Included In: Medical Devices / Diagnostics
Article Date: 10 Mar 2011 – 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:not yet rated

Healthcare Prof:not yet rated

University Hospitals (UH) Case Medical Center is conducting the first ever pilot study to test a new procedure using “heat therapy” or local radiofrequency energy to treat premature ejaculation. The procedure is called image-guided neurothermal modulation, referring to the energy produced by radio waves directed with a probe to modulate or lessen the sensation of a nerve.

Rituximab Combined With A TNF Inhibitor And Methotrexate Shows No Safety Signal In RA Treatment

Main Category: Arthritis / Rheumatology
Article Date: 09 Mar 2011 – 1:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:not yet rated

Healthcare Prof:not yet rated

A recent trial of rituximab in combination with a tumor necrosis factor (TNF) inhibitor and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) found the safety profile to be consistent with other RA trials with TNF inhibitors. While the trial reported no new safety risks, clear evidence of an efficacy advantage in RA patients receiving the combination therapy was not observed in this study sample. Results of the trial are published in the March issue of Arthritis Rheumatism, a peer-reviewed journal of the American College of Rheumatology.

Sildenafil Reduces Raynaud’s Frequency In Patients With Systemic Sclerosis

Main Category: Arthritis / Rheumatology
Also Included In: Immune System / Vaccines;  Clinical Trials / Drug Trials
Article Date: 09 Mar 2011 – 1:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:not yet rated

Healthcare Prof:not yet rated

Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects. Full findings are available in the March issue of Arthritis Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).

Judge Rules In Favor Of Plaintiffs Seeking Medicare Coverage Of Off-Label, Medically Necessary Drugs

Main Category: Medicare / Medicaid / SCHIP
Article Date: 09 Mar 2011 – 3:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

In a decision published yesterday, a federal judge held that regulations that bar Medicare drug plans from covering medically necessary, “off-label” prescription drugs are unreasonable and do not reflect Congress’s intent to cover such drugs. The judge ruled that the plaintiffs’ off-label drug costs should be covered because the denial of coverage was based upon an “unsound interpretation” of the federal law providing drug coverage to people with Medicare.